These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 17106517

  • 1. CD30 expression utilization for the accuracy of classical Hodgkin's lymphoma staging.
    Flangea C, Potencz E, Mihăescu R, Anghel A, Gîju S, Motoc M, Dogaru C.
    Rom J Morphol Embryol; 2006; 47(2):113-7. PubMed ID: 17106517
    [Abstract] [Full Text] [Related]

  • 2. Bcl-2 expression in Hodgkin's lymphoma progression.
    Flangea C, Potencz E, Mihăescu R, Gîju S, Anghel A.
    Rom J Morphol Embryol; 2008; 49(3):357-63. PubMed ID: 18758641
    [Abstract] [Full Text] [Related]

  • 3. Immunophenotype of Reed-Sternberg and Hodgkin's cells in sequential biopsy specimens of Hodgkin's disease: a paraffin-section immunohistochemical study using the heat-induced epitope retrieval method.
    Vasef MA, Alsabeh R, Medeiros LJ, Weiss LM.
    Am J Clin Pathol; 1997 Jul; 108(1):54-9. PubMed ID: 9208978
    [Abstract] [Full Text] [Related]

  • 4. Interfollicular Hodgkin's disease: an uncommon pattern that may cause diagnostic difficulty.
    Basu D, Roy SK.
    Indian J Pathol Microbiol; 2006 Apr; 49(2):221-5. PubMed ID: 16933719
    [Abstract] [Full Text] [Related]

  • 5. Classical Hodgkin's disease. Clinical impact of the immunophenotype.
    von Wasielewski R, Mengel M, Fischer R, Hansmann ML, Hübner K, Franklin J, Tesch H, Paulus U, Werner M, Diehl V, Georgii A.
    Am J Pathol; 1997 Oct; 151(4):1123-30. PubMed ID: 9327746
    [Abstract] [Full Text] [Related]

  • 6. Morphologically normal, CD30-negative B-lymphocytes with chromosome aberrations in classical Hodgkin's disease: the progenitor cell of the malignant clone?
    Jansen MP, Hopman AH, Bot FJ, Haesevoets A, Stevens-Kroef MJ, Arends JW, Jox A, Wolf J, Ramaekers FC, Schouten HC.
    J Pathol; 1999 Dec; 189(4):527-32. PubMed ID: 10629553
    [Abstract] [Full Text] [Related]

  • 7. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
    Massarelli G, Onida GA, Piras MA, Marras V, Mura A, Tanda F.
    Anticancer Res; 1999 Dec; 19(5B):3933-8. PubMed ID: 10628334
    [Abstract] [Full Text] [Related]

  • 8. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.
    Diepstra A, van Imhoff GW, Karim-Kos HE, van den Berg A, te Meerman GJ, Niens M, Nolte IM, Bastiaannet E, Schaapveld M, Vellenga E, Poppema S.
    J Clin Oncol; 2007 Jul 20; 25(21):3101-8. PubMed ID: 17536082
    [Abstract] [Full Text] [Related]

  • 9. Hodgkin's disease, mixed cellularity type, with a B-cell immunophenotype. Report of a case and literature review.
    Siebert JD, McClure SP, Banks PM, Gulley ML.
    Arch Pathol Lab Med; 1995 May 20; 119(5):474-9. PubMed ID: 7538289
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic accuracy of imprint cytology in the assessment of Hodgkin's disease in Japan.
    Funamoto Y, Nagai M, Haba R, Ishikawa M, Kishida F, Kohno K, Matsunaga T, Kushida Y, Kobayashi S.
    Diagn Cytopathol; 2005 Jul 20; 33(1):20-5. PubMed ID: 15945083
    [Abstract] [Full Text] [Related]

  • 11. The immunohistochemistry of Hodgkin's disease.
    Said JW.
    Semin Diagn Pathol; 1992 Nov 20; 9(4):265-71. PubMed ID: 1362283
    [Abstract] [Full Text] [Related]

  • 12. Hodgkin's lymphoma of T-cell type: clonal association with a CD30+ cutaneous lymphoma.
    Kadin ME, Drews R, Samel A, Gilchrist A, Kocher O.
    Hum Pathol; 2001 Nov 20; 32(11):1269-72. PubMed ID: 11727269
    [Abstract] [Full Text] [Related]

  • 13. A Phase I study with an anti-CD30 ricin A-chain immunotoxin (Ki-4.dgA) in patients with refractory CD30+ Hodgkin's and non-Hodgkin's lymphoma.
    Schnell R, Staak O, Borchmann P, Schwartz C, Matthey B, Hansen H, Schindler J, Ghetie V, Vitetta ES, Diehl V, Engert A.
    Clin Cancer Res; 2002 Jun 20; 8(6):1779-86. PubMed ID: 12060617
    [Abstract] [Full Text] [Related]

  • 14. [Pathology of Hodgkin's lymphoma].
    Hansmann ML, Willenbrock K.
    Verh Dtsch Ges Pathol; 2003 Jun 20; 87():53-7. PubMed ID: 16888894
    [Abstract] [Full Text] [Related]

  • 15. Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma.
    Bräuninger A, Wacker HH, Rajewsky K, Küppers R, Hansmann ML.
    Cancer Res; 2003 Apr 01; 63(7):1644-51. PubMed ID: 12670918
    [Abstract] [Full Text] [Related]

  • 16. Usefulness of K-1 (CD-30) marker in Hodgkin's disease.
    Shakoor KA, Saleh A, Khanzada MS.
    J Pak Med Assoc; 2002 Oct 01; 52(10):442-7. PubMed ID: 12553671
    [Abstract] [Full Text] [Related]

  • 17. An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA') is a potent immunotoxin against a Hodgkin-derived cell line.
    Klimka A, Barth S, Matthey B, Roovers RC, Lemke H, Hansen H, Arends JW, Diehl V, Hoogenboom HR, Engert A.
    Br J Cancer; 1999 Jun 01; 80(8):1214-22. PubMed ID: 10376974
    [Abstract] [Full Text] [Related]

  • 18. Follicular Hodgkin's disease.
    Ashton-Key M, Thorpe PA, Allen JP, Isaacson PG.
    Am J Surg Pathol; 1995 Nov 01; 19(11):1294-9. PubMed ID: 7573692
    [Abstract] [Full Text] [Related]

  • 19. Nodular lymphocyte predominant Hodgkin's disease and anaplastic large-cell (CD30+) lymphoma: distinct entities or nonspecific patterns?
    Menestrina F, Chilosi M, Scarpa A.
    Semin Diagn Pathol; 1995 Aug 01; 12(3):256-69. PubMed ID: 8545592
    [Abstract] [Full Text] [Related]

  • 20. An anti-CD30 chimeric receptor that mediates CD3-zeta-independent T-cell activation against Hodgkin's lymphoma cells in the presence of soluble CD30.
    Hombach A, Heuser C, Sircar R, Tillmann T, Diehl V, Pohl C, Abken H.
    Cancer Res; 1998 Mar 15; 58(6):1116-9. PubMed ID: 9515791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.